TABLE 2.
The prevalence of hypertension based on grades and cardiovascular risk stratifications among cancer patients
| Total | CRC | TC | RCC | LC | HCC | |
| HTN (n) | 5847 | 1380 | 340 | 409 | 3072 | 646 |
| Grade classification [n (%)] | ||||||
| Grade I | 184 (3.9) | 38 (3.6) | 21 (7.7) | 7 (2.4) | 99 (3.8) | 19 (3.9) |
| Grade II | 955 (20.4) | 228 (21.8) | 46 (16.9) | 65 (22.6) | 521 (20.2) | 95 (19.4) |
| Grade III | 3541 (75.7) | 779 (74.5) | 205 (75.4) | 216 (75) | 1965 (76) | 376 (76.7) |
| Cardiovascular risk stratification [n (%)] | ||||||
| Low risk | 35 (0.8) | 9 (0.9) | 5 (2.0) | 1 (0.4) | 18 (0.7) | 2 (0.4) |
| Moderate risk | 157 (3.6) | 35 (3.6) | 11 (4.5) | 5 (1.9) | 90 (3.7) | 16 (3.6) |
| High risk | 445 (10.2) | 105 (10.9) | 27 (11) | 25 (9.3) | 247 (10.2) | 41 (8.9) |
| Very high risk | 3729 (85.4) | 818 (84.6) | 203 (82.5) | 239 (88.6) | 2066 (85.3) | 403 (87.2) |
Data were presented using frequency and percentage. CRC, colorectal cancer; HCC, hepatocellular carcinoma; HTN, hypertension; LC, lung cancer; RCC, renal cell carcinoma; TC, thyroid cancer.